Nitric oxide- biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis

Atherosclerosis

Volumn 118, Issue SUPPL., 1995, Pages

  Radomski, Marek W ^a   Salas, Eduardo ^a  

^a ALBERTA ENVIRONMENT AND PARKS   (Canada)

Author keywords

Atherosclerosis; Nitric oxide; Pathology; Vascular physiology

Indexed keywords

ARGININE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ATHEROSCLEROSIS; CONFERENCE PAPER; HUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHYSIOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; ARTERIOSCLEROSIS; CORONARY VESSELS; CRICETINAE; ENDOTHELIUM, VASCULAR; GUINEA PIGS; HOMEOSTASIS; HUMANS; NITRIC OXIDE;

EID: 0029591748     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)90075-6     Document Type: Article

References (122)

1. Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to escherichia coli lipopolysaccharide
2. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite
3. The obligatory role of endothelial cells in the relaxation of arterial smoth muscle by acetylcholine
4. Studies on relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and that endothelium-derived relaxing factor is nitric oxide
5. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
6. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
7. Vascular endothelial cells synthesize nitric oxide from l-arginine
8. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
9. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets
10. An Larginine:nitric oxide pathway present in human platelets regulates aggregation
11. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide
12. Nitric oxide as a secretory product of mammalian cells
13. G-hydroxy-l-arginine by nitric oxide synthase: Evidence for the involvement of the heme in catalysis
14. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
15. Molecular cloning and characterization of human endothelial nitric oxide synthase
16. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells
17. Isolation of nitric oxide synthase from human platelets
18. Macrophage oxidation of l-arginine to nitric oxide, nitrite and nitrate. Tetrahydrobiopterin is required as a cofactor
19. FAD and GSH participate in macrophage synthesis of nitric oxide
20. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells
21. Nitric oxide synthases in mammals
22. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain
23. Synthesis of nitric oxide by the hemocytes of the American horseshoe crab (Limulus polyphemus)
24. Glucocorticoids inhibit the expression of an inducible but not the constitutive nitric oxide synthase in vascular endothelial cells
25. Dexamethasone prevents the induction by endotgxin of a nitric oxide synthase and the associated effects on vascular tone
26. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages
27. Nitric oxide diffusion coefficients in solutions, proteins and membranes determined by phosphorescence
28. Oxidation of nitric oxide by oxygen in biological systems monitored by porphyrinic microsensor
29. Reactions and diffusion of nitric oxide and peroxynitrite
30. Paradoxical fate and biological action of peroxynitrite on human platelets
31. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
32. Restoration of the reponsiveness of purified guanylate cyclase to nitrosoguanidine nitric oxide, and related activators by heme and heme proteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation
33. Selective sequestration of nitric oxide by subcellular components of vascular smooth muscle and platelets: relationship to nitric oxide stimulation of the soluble guanylyl cyclase
34. Soluble guanylyl cyclase and platelet function
35. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system
36. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition
37. Increase of human platelet serotonin uptake by atypical histamine receptors
38. Inhibitory action of cyclic GMP on secretion, phosphoinositide hydrolysis and calcium mobiliza tion in thrombin-stimulated human platelets
39. Cyclic GMP increases the rate of the calcium extrusion pump in intact platelets but has no direct effect on the dense tubular calcium accumulation system
40. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP
41. Cyclic GMP analogs inhibit- gamma thrombin-induced arachidonic acid release in human platelets
42. Comparative pharmacology of analogues of S-nitroso-N-acetyl-Dl-peni-cillamine in platelets
43. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine
44. Efflux of cyclic GMP from activated platelets
45. Selective inhibition of the 12-lipoxygenase pathway of arachidonic acid metabolism by l-arginine or sodium nitroprusside in intact human platelets
46. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron
47. Inactivation of ribonucleotide reductase by nitric oxide
48. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors
49. S-Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds
50. Direct measurement of nitric oxide in humans
51. The role of endothelium-derived nitric oxide in the regulation of blood pressure
52. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
53. Effects of intracoronary injection of acetylcholine on coronary arterial diameter
54. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
55. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis
56. Crucial role of the endothelium in the vasodilator response to increased flow in vivo
57. Mechanisms of shear stress-dependent NO release
58. The role of nitric oxide in the cerebrovascular flow response to stimulation of postganglionic parasympathetic nerves in the rat
59. Nitrergic transmission: nitric oxide as a mediator of non-adrnergic non-cholinergic neuro-effector transmission
60. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat
61. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
62. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets
63. Nitric oxide release from resting platelets
64. Role of cyclic nucleotides in rapid platelet adhesion to collagen
65. Characterization of the l-argininenitric oxide pathway in human platelets
66. Direct electrochemical measurement of nitric oxide released from human platelets
67. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
68. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells
69. Thrombininduced platelet adhesion to endothelium is modified by endothelial derived relaxing factor (EDRF)
70. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed
71. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide
72. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation
73. Endothelium-derived relaxing factor inhibits platelet activation
74. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin
75. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP
76. Inhibition of intravascular platelet aggregation by endotheliumderived relaxing factor: reversal by red blood cells
77. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: Blockade of aggregation and secretion by an aspirin-insensitive mechanism
78. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of reccurent platelet activation
79. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries
80. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation
81. G-monomethyl-l-arginine increases platelet deposition on damaged endothelium in vivo. A scanning electron microscopy study
82. Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse
83. Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo
84. In vivo EDRF activity influences platelet function
85. Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: Involvement of endothe lium-derived relaxing factor
86. Influence of endotheliumderived relaxing factor on platelet function and hemostasis in vivo
87. Platelet-endothelium interactions in humans: Changes in platelet cyclic guanosine monophosphate content in pa tients with endothelial dysfunction
88. Nitric oxide synthase inhibition and platelet function
89. Oral l-arginine in humans: effects on platelet aggregation hemodynamics and endothelium-dependent dilation
90. l-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects
91. Nitric oxide: An endogenous modulator of leukocyte adhesion
92. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits
93. Colesterol feeding impairs endothelium-dependent relaxation of rabbit aorta
94. Effect of hypercholesterolemia on vascular reactivity of in the rabbit
95. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates
96. Dietary cod liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries
97. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophospahate formation in atheroscle rotic human coronary artery and rabbit aorta
98. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries
99. Systemic nature of endothelial dysfunction in atherosclerosis
100. Modification of low density lipoproteins by endothelial cells involves lipid peroxidation and degrada tion of low density lipoprotein phispholipids
101. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins
102. LPC in oxidized LDL elicits vasoconstriction and inhibits endothelium-dependent relaxation
103. Beneficial effect of cholesterol-lowering therapy on coronary endotheliumdependent relaxation in hypercholesterolaemic patients
104. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity
105. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit
106. Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts
107. High density lipoprotein antagonizes the stimulatory effect of low density liporotein on platelet function by affecting l-arginine-nitric oxide pathway
108. Induction of a calcium-independent NO synthase by hepercholesterolaemia in the rabbit
109. Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis
110. Megakaryocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase
111. Superoxide anion is involved in the breakdown of endotheliumderived vascular relaxing factor
112. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
113. Extensive nitration of protein tyrosines observed in human atherosclerosis detected by immunohistochemistry
114. Superoxide and peroxynitrite in atherosclerosis
115. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart
116. l-arginine augments endothelium-dependent vasodilatation in cholesterol-fed rabbits
117. Cellular mechanisms of atherogenesis and the effects of nitric oxide
118. l-arginine improves endothelium-dependent relaxation in hypercholesterolemic humans
119. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolemic patients by l-arginine
120. l-arginine attenuates platelet reactivity in hypercholestorolemic rabbits